AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29921891 — intervention group
Group type: COMPARATOR
Intervention: Anthracycline-based regimens
Number of subjects: 553
Study 29921891 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant radiotherapy for non‐parameningeal group‐I patients
Number of subjects: 553
Study 27230727 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality diet
Number of subjects: 540
Study 27230727 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate levels of physical activity
Number of subjects: 540
Study 27230727 — intervention group
Group type: EXPERIMENTAL
Intervention: Managerial/supervisory position
Number of subjects: 540
Study 27230727 — intervention group
Group type: EXPERIMENTAL
Intervention: Central obesity
Number of subjects: 540
Study 25122038 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg, over 40 min)
Number of subjects: 16
Study 23822578 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor‐based triple therapy
Number of subjects: 190
Study 23822578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study 23822578 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori-negative group (after eradication)
Number of subjects: 190
Study 23822578 — intervention group
Group type: COMPARATOR
Intervention: H. pylori-positive group (persistent infection)
Number of subjects: 190
Study 21373300 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia-iliaca block with bupivacaine and parenteral saline injection (Group A)
Number of subjects: 154
Study 21373300 — intervention group
Group type: COMPARATOR
Intervention: IV NSAID injection with fascia-iliaca block (Group B)
Number of subjects: 154
Study 18422393 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin and clopidogrel (dual antiplatelet therapy)
Number of subjects: 0
Study 18422393 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel pretreatment prior to PCI
Number of subjects: 0
Study 18422393 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel therapy duration
Number of subjects: 0
Study 18422393 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0
Study 18422393 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance to aspirin and clopidogrel
Number of subjects: 0
Study 16634993 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucerna SR 323 ml
Number of subjects: 14
Study 16634993 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensure high calcium 315 ml
Number of subjects: 14
Study 16634993 — intervention group
Group type: COMPARATOR
Intervention: Glucose 75 g
Number of subjects: 14
Study 14516896 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose dobutamine infusion
Number of subjects: 24
Study 10854861 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH (enoxaparin sodium, 40 mg daily) + low-dose aspirin (100 mg daily) in the first trimester (group 1, n=14)
Number of subjects: 46
Study 10854861 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH (enoxaparin sodium, 40 mg daily) + low-dose aspirin (100 mg daily) in the second trimester (group 2, n=17)
Number of subjects: 46
Study 10854861 — intervention group
Group type: COMPARATOR
Intervention: Low-dose aspirin alone (group 3, n=15)
Number of subjects: 46
Study 9190135 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-reflection coated lenses
Number of subjects: 46
Study 9190135 — intervention group
Group type: COMPARATOR
Intervention: Uncoated lenses
Number of subjects: 46
Study 8227478 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 mg methylprednisolone (Medrol Tablets)
Number of subjects: 31
Study 8227478 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg methylprednisolone (Medrol Tablets)
Number of subjects: 31
Study 8227478 — intervention group
Group type: COMPARATOR
Intervention: 0 mg methylprednisolone (placebo)
Number of subjects: 31
Study 3541502 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg levothyroxine daily
Number of subjects: 29
Study 3541502 — intervention group
Group type: COMPARATOR
Intervention: No medication
Number of subjects: 29
Study 3541502 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 29
Study 3541502 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine thyroxine treatment
Number of subjects: 29
Study 31350962 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin, GnRH antagonist, and GH from the eighth day of the cycle for about 5 days (n = 34)
Number of subjects: 92
Study 31350962 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin, GnRH antagonist, and GH from the third day of the previous cycle for about 20 days (n = 32)
Number of subjects: 92
Study 31350962 — intervention group
Group type: COMPARATOR
Intervention: Gonadotropin, GnRH antagonist, and placebo from the eighth day of the cycle for about 5 days (n = 26)
Number of subjects: 92
Study 30337309 — intervention group
Group type: COMPARATOR
Intervention: Nurse support (12-week walking programmes and PA diaries delivered by post or through three PA consultations with practice nurses)
Number of subjects: 1023
Study 30337309 — intervention group
Group type: COMPARATOR
Intervention: Postal group (pedometer intervention delivered by post)
Number of subjects: 1023
Study 26933848 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg preoperatively)
Number of subjects: 2100
Study 26933848 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2100
Study 24238651 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Bearing (MB) prosthesis
Number of subjects: 16
Study 24238651 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed Bearing (FB) prosthesis
Number of subjects: 16
Study 24238651 — intervention group
Group type: COMPARATOR
Intervention: Control group (age and gender matched)
Number of subjects: 16
Study 22545014 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymerized collagen (2 mL, 6 intraarticular injections over 3 months)
Number of subjects: 19
Study 22545014 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 mL, 6 intraarticular injections over 3 months)
Number of subjects: 19
Study 20682030 — intervention group
Group type: EXPERIMENTAL
Intervention: Singing classes (6-week course, twice weekly)
Number of subjects: 28
Study 20682030 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 28
Study 18242412 — intervention group
Group type: EXPERIMENTAL
Intervention: ACCP-recommended VTE prophylaxis for surgical patients at risk
Number of subjects: 68183
Study 18242412 — intervention group
Group type: COMPARATOR
Intervention: ACCP-recommended VTE prophylaxis for medical patients at risk
Number of subjects: 68183
Study 18242412 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients at risk for VTE
Number of subjects: 68183
Study 18242412 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical patients at risk for VTE
Number of subjects: 68183
Study 18242412 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical patients at risk for VTE
Number of subjects: 68183
Study 15901862 — intervention group
Group type: EXPERIMENTAL
Intervention: Training traditional birth attendants and providing disposable delivery kits; integration with Lady Health Workers and obstetrical teams for antenatal care.
Number of subjects: 20157
Study 15901862 — intervention group
Group type: COMPARATOR
Intervention: Usual care provided in control talukas.
Number of subjects: 20157
Study 12873240 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol reduction motivational interview (MI)
Number of subjects: 120
Study 12873240 — intervention group
Group type: EXPERIMENTAL
Intervention: Information pack (IP)
Number of subjects: 120
Study 12873240 — intervention group
Group type: COMPARATOR
Intervention: Matched controls (not receiving MI or IP)
Number of subjects: 120
Study 12873240 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined MI-IP group
Number of subjects: 120
Study 12873240 — intervention group
Group type: EXPERIMENTAL
Intervention: Dependent and harmful consumers (AUDIT classifications)
Number of subjects: 120
Study 10570373 — intervention group
Group type: EXPERIMENTAL
Intervention: Photopheresis for 1 year
Number of subjects: 19
Study 10570373 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 19
Study 10570373 — intervention group
Group type: EXPERIMENTAL
Intervention: Photopheresis after crossover
Number of subjects: 19
Study 10570373 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunologic parameters
Number of subjects: 19
Study 10570373 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 19
Study 8877596 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril 5 mg
Number of subjects: 6
Study 8877596 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril 20 mg
Number of subjects: 6
Study 8877596 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 1577045 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallopamil 100 mg b.i.d.
Number of subjects: 20
Study 1577045 — intervention group
Group type: COMPARATOR
Intervention: Gallopamil 100 mg o.d.
Number of subjects: 20
Study 4063326 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-50 g Palatinit/d
Number of subjects: 11
Study 31733785 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbosacral orthosis (LSO) with routine physical therapy
Number of subjects: 44
Study 31733785 — intervention group
Group type: COMPARATOR
Intervention: Routine physical therapy alone
Number of subjects: 44
Study 30672179 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional combined with magnetotherapy group (observation 1)
Number of subjects: 93
Study 30672179 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional combined with vaccaria seed group (observation 2)
Number of subjects: 93
Study 30672179 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (control)
Number of subjects: 93
Study 26142227 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser photocoagulation (LC) in APROP (Group 1)
Number of subjects: 75
Study 26142227 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser photocoagulation (LC) in TD (Group 2)
Number of subjects: 75
Study 26142227 — intervention group
Group type: COMPARATOR
Intervention: No laser photocoagulation (Group 3)
Number of subjects: 75
Study 26142227 — intervention group
Group type: COMPARATOR
Intervention: Full-term children (Group 4)
Number of subjects: 75
Study 26142227 — intervention group
Group type: EXPERIMENTAL
Intervention: Groups 1 and 2
Number of subjects: 75
Study 26142227 — intervention group
Group type: COMPARATOR
Intervention: Groups 3 and 4
Number of subjects: 75
Study 26142227 — intervention group
Group type: COMPARATOR
Intervention: Groups 2 and 3
Number of subjects: 75
Study 26142227 — intervention group
Group type: EXPERIMENTAL
Intervention: Groups 1-4
Number of subjects: 75
Study 25303111 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho-education intervention by midwives, including telephone counseling at 24 and 34 weeks of pregnancy.
Number of subjects: 170
Study 25303111 — intervention group
Group type: COMPARATOR
Intervention: Usual care offered by public maternity services (Control group).
Number of subjects: 170
Study 25303111 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho-education intervention by midwives.
Number of subjects: 170
Study 22701683 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir 500 mg twice daily
Number of subjects: 148
Study 22701683 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 20146902 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital rehabilitation with no telephone follow‐up
Number of subjects: 240
Study 20146902 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital rehabilitation with telephone follow‐up
Number of subjects: 240
Study 20146902 — intervention group
Group type: EXPERIMENTAL
Intervention: Community rehabilitation with no telephone follow‐up
Number of subjects: 240
Study 20146902 — intervention group
Group type: EXPERIMENTAL
Intervention: Community rehabilitation with telephone follow‐up
Number of subjects: 240
Study 20146902 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone follow-up
Number of subjects: 240
Study 20146902 — intervention group
Group type: COMPARATOR
Intervention: No telephone follow-up
Number of subjects: 240
Study 17666307 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee sleeve (neoprene sleeve)
Number of subjects: 50
Study 17666307 — intervention group
Group type: COMPARATOR
Intervention: No knee sleeve
Number of subjects: 50
Study 16193773 — intervention group
Group type: EXPERIMENTAL
Intervention: New 25-dimensional feature space
Number of subjects: 56
Study 16193773 — intervention group
Group type: COMPARATOR
Intervention: Previous 19-dimensional feature space
Number of subjects: 56
Study 16193773 — intervention group
Group type: COMPARATOR
Intervention: Combined 44-dimensional feature space
Number of subjects: 56
Study 12207067 — intervention group
Group type: EXPERIMENTAL
Intervention: Aboral pouch with preserved duodenal passage
Number of subjects: 17
Study 10520146 — intervention group
Group type: EXPERIMENTAL
Intervention: True occlusal adjustment
Number of subjects: 40
Study 10520146 — intervention group
Group type: COMPARATOR
Intervention: Mock adjustment
Number of subjects: 40
Study 8541200 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopexamine hydrochloride at a rate of 2 micrograms/kg/min (n = 15)
Number of subjects: 32
Study 8541200 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline solution as placebo (n = 17)
Number of subjects: 32
Study 1791015 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained Release (SR) Theophylline plus Hydroxyethyltheophylline
Number of subjects: 0
Study 1791015 — intervention group
Group type: COMPARATOR
Intervention: Conventional Theophylline plus Hydroxyethyltheophylline
Number of subjects: 0
Study 1791015 — intervention group
Group type: COMPARATOR
Intervention: Aminophylline Tablets
Number of subjects: 0
Study 7037758 — intervention group
Group type: EXPERIMENTAL
Intervention: Viloxazine
Number of subjects: 20
Study 7037758 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 20
Study 30931667 — intervention group
Group type: EXPERIMENTAL
Intervention: Resurfacing hip arthroplasty (RHA)
Number of subjects: 34
Study 30931667 — intervention group
Group type: COMPARATOR
Intervention: Total hip arthroplasty (THA)
Number of subjects: 34
Study 29479726 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary prevention programme
Number of subjects: 0
Study 29479726 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study 27781255 — intervention group
Group type: EXPERIMENTAL
Intervention: Less than 3 months treatment group
Number of subjects: 35
Study 27781255 — intervention group
Group type: COMPARATOR
Intervention: More than 3 months treatment group
Number of subjects: 35
Study 24859422 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsolateral pre-frontal cortex (DLPFC) stimulation
Number of subjects: 20
Study 24859422 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior parietal cortex (PPC) stimulation
Number of subjects: 20
Study 22617278 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative immunonutrition (IN)
Number of subjects: 152
Study 22617278 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric‐isonitrogenous nutrition (ICN)
Number of subjects: 152
Study 21171981 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention in passive smoking after specific training
Number of subjects: 0
Study 21171981 — intervention group
Group type: COMPARATOR
Intervention: Habitual care (Control)
Number of subjects: 0
Study 18065143 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon 1-b injections
Number of subjects: 0
Study 15741226 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha 2b (IFN-alpha-2b)
Number of subjects: 90
Study 15741226 — intervention group
Group type: COMPARATOR
Intervention: No maintenance therapy (control)
Number of subjects: 90
Study 11997800 — intervention group
Group type: EXPERIMENTAL
Intervention: RetCam 120 images acquired by a neonatal nurse at examination 1 (32 to 34 weeks)
Number of subjects: 46
Study 11997800 — intervention group
Group type: EXPERIMENTAL
Intervention: RetCam 120 images acquired by a neonatal nurse at examination 2 (38 to 40 weeks)
Number of subjects: 46
Study 11997800 — intervention group
Group type: COMPARATOR
Intervention: Examination by an experienced ophthalmologist (control)
Number of subjects: 46
Study 9529260 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing 100% oxygen for 15 minutes
Number of subjects: 14
Study 9529260 — intervention group
Group type: COMPARATOR
Intervention: Breathing room air for 15 minutes
Number of subjects: 14
Study 8746390 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-drug treatments
Number of subjects: 159
Study 8746390 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroleptics
Number of subjects: 159
Study 8746390 — intervention group
Group type: EXPERIMENTAL
Intervention: Drugs (general)
Number of subjects: 159
Study 8746390 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepines, antidepressants, and other substances
Number of subjects: 159
Study 2534464 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual stimulation
Number of subjects: 6
Study 2534464 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation at 2 Hz
Number of subjects: 6
Study 2534464 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation at 80 Hz
Number of subjects: 6
Study 2534464 — intervention group
Group type: COMPARATOR
Intervention: Superficial-acupuncture (placebo)
Number of subjects: 6
Study 761539 — intervention group
Group type: EXPERIMENTAL
Intervention: Proglumide (1200 mg daily)
Number of subjects: 51
Study 761539 — intervention group
Group type: COMPARATOR
Intervention: Magnesium tricilicate (1320 mg daily, active placebo)
Number of subjects: 51
Study 761539 — intervention group
Group type: EXPERIMENTAL
Intervention: Proglumide
Number of subjects: 51
Study 30040011 — intervention group
Group type: EXPERIMENTAL
Intervention: Maitland grade III mobilization
Number of subjects: 48
Study 30040011 — intervention group
Group type: COMPARATOR
Intervention: Maitland grade I mobilization
Number of subjects: 48
Study 28619300 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Spinal Orthopedic Manipulation (TCSOM)
Number of subjects: 60
Study 28619300 — intervention group
Group type: COMPARATOR
Intervention: Pinaverium Bromide (PBD)
Number of subjects: 60
Study 24797706 — intervention group
Group type: EXPERIMENTAL
Intervention: Online intervention to improve gluten-free diet adherence
Number of subjects: 0
Study 24797706 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention modules
Number of subjects: 0
Study 23835688 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy germ pasta
Number of subjects: 10
Study 23835688 — intervention group
Group type: COMPARATOR
Intervention: Conventional pasta
Number of subjects: 10
Study 21942655 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA 10 mg daily
Number of subjects: 48
Study 21942655 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT (1 mg estradiol + 5 mg dihydrogesterone)
Number of subjects: 48
Study 21942655 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg daily
Number of subjects: 48
Study 21942655 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA, HRT, and tibolone
Number of subjects: 48
Study 21942655 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D (400 IU)
Number of subjects: 48
Study 19254400 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous fascial sling (AFS)
Number of subjects: 41
Study 19254400 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 41
Study 19254400 — intervention group
Group type: COMPARATOR
Intervention: Quality of life assessment at 36 months
Number of subjects: 41
Study 17661558 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU/day vitamin D
Number of subjects: 25
Study 17661558 — intervention group
Group type: EXPERIMENTAL
Intervention: 4000 IU/day vitamin D
Number of subjects: 25
Study 17661558 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (2000 IU/day and 4000 IU/day)
Number of subjects: 25
Study 15534514 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellar resurfacing
Number of subjects: 90
Study 15534514 — intervention group
Group type: COMPARATOR
Intervention: Nonresurfacing of the patella
Number of subjects: 90
Study 15534514 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90
Study 11295026 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation A (800 microg folic acid, 6 microg vitamin B12, 10 mg vitamin B6)
Number of subjects: 0
Study 11295026 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation B (160 microg folic acid, no vitamin B12, 10 mg vitamin B6)
Number of subjects: 0
Study 11295026 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9399608 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem CD 246 mg
Number of subjects: 118
Study 9399608 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 7703633 — intervention group
Group type: EXPERIMENTAL
Intervention: TCM-WM therapy
Number of subjects: 0
Study 7703633 — intervention group
Group type: COMPARATOR
Intervention: Western medicine alone
Number of subjects: 0
Study 3063832 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspiration of middle ear effusions prior to ventilation tube insertion
Number of subjects: 55
Study 3063832 — intervention group
Group type: COMPARATOR
Intervention: Non-aspirated middle ear
Number of subjects: 55
Study 29672567 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led group medical visits
Number of subjects: 250
Study 29672567 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 250
Study 26887645 — intervention group
Group type: EXPERIMENTAL
Intervention: TESSYS
Number of subjects: 106
Study 26887645 — intervention group
Group type: COMPARATOR
Intervention: FD
Number of subjects: 106
Study 25636669 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral injection of technetium-99m macroaggregated albumin (37 MBq/1 mCi per injection)
Number of subjects: 14
Study 25636669 — intervention group
Group type: COMPARATOR
Intervention: Unilateral injection of technetium-99m macroaggregated albumin (37 MBq/1 mCi per injection)
Number of subjects: 14
Study 23889978 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted reflection on life events and ultimate life goals using a brief structured interview scheme supported by an e-application (two consultations with a spiritual counsellor)
Number of subjects: 0